24 Paid Clinical Research Studies in Los Angeles, California

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase1

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

The purpose of this trial is to estimate the recommended dose (RD) of \[177Lu\]Lu-NeoB in combination with ribociclib and fulvestrant in participants with estrogen receptor (ER) po

πŸ“ UCLA Jonsson Comp Cancer Center β€” Los Angeles, California

πŸ’΅ During screening, study participants will receive the investigational imaging agent \[68Ga\]Ga-NeoB.

View Study & Checklist βž”
Phase1

Immunological Tolerance in Patients With Mismatched Kidney Transplants

This study seeks to determine if administration of the drug belumosudil (KD025) will be safe and improve transplant tolerance in subjects undergoing combined Human Leukocyte Antige

πŸ“ University of California, Los Angeles β€” Los Angeles, California

πŸ’΅ Subjects will receive belumosudil 200 mg by mouth daily from day 28 following the kidney transplant through month 24.

View Study & Checklist βž”
Phase1 / Phase2

Microdystrophin Gene Transfer Study in Adolescents and Children With DMD

This is a controlled, open-label, single-ascending dose study to evaluate the safety and tolerability of SGT-001 in adolescents and children with Duchenne muscular dystrophy (DMD).

πŸ“ David Geffen School of Medicine at UCLA β€” Los Angeles, California

πŸ’΅ Participants will receive a single intravenous (IV) infusion of SGT-001 and will be followed for approximately 5 years.

View Study & Checklist βž”
Interventional Protocol

Open Label, 6-month Study for High Frequency and Chronic Migraine,

This is a prospective, multi-center, unblinded study in patients with migraine (β‰₯ 8 MMDs/month) requiring preventive treatment. Enrolled patients will receive DAX administered subc

πŸ“ The Los Angeles Headache Center β€” Los Angeles, California

πŸ’΅ Enrolled patients will receive DAX administered subcutaneously using an established, published, legacy injection paradig

View Study & Checklist βž”
Observational / Diagnostic

Clinical Decision Support for PrEP

Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the federal initiative to end the HIV epidemic. However, healthcare providers lack tools to identify patients wh

πŸ“ Saban Community Clinic β€” Los Angeles, California

View Study & Checklist βž”
Observational / Diagnostic

acTBS Treatment for Inpatient Subjects With Suicidality

This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will en

πŸ“ Resnick Neuropsychiatric Hospital β€” Los Angeles, California

πŸ’΅ Subjects will receive up to five sessions of acTBS daily, on consecutive weekdays.

View Study & Checklist βž”
Observational / Diagnostic

Pharmacist Intervention to Reduce Post-Hospitalization Utilization

This is a randomized trial testing a peri- and post-discharge pharmacist-led medication management intervention on post-discharge utilization, including both readmissions and emerg

πŸ“ Cedars-Sinai Medical Center β€” Los Angeles, California

πŸ’΅ For the control arm, patients will receive usual care, which includes medication reconciliation at hospital admission.

View Study & Checklist βž”
Phase1 / Phase2

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

This study is being done to assess the feasibility of pembrolizumab (study drug) combined with standard radiation to the tumor (tumor boost) before patients undergo standard treatm

πŸ“ Cedars-Sinai Medical Center β€” Los Angeles, California

πŸ’΅ Study participants will receive two doses of the study drug intravenously (through the vein) before their planned breast

View Study & Checklist βž”
Phase1 / Phase2

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

The purpose of this study is to determine the appropriate dosage, safety and effectiveness of the study drug, IPN01194 in adults with advanced solid tumours. The participants in t

πŸ“ The Angeles Clinic and Research Institute - California β€” Los Angeles, California

πŸ’΅ In this study, all participants will receive the study drug, which will be taken by mouth (orally).

View Study & Checklist βž”